Dr. Bradley Discusses Key Lung Cancer Topics

Video

In Partnership With:

Dr. Jeffrey Bradley from Washington University School of Medicine Discusses Key Lung Cancer Topics

Jeffrey D. Bradley, MD, S. Lee Kling, associate professor, Radiation Oncology, chief, Thoracic Service, director, S. Lee Kling Center for Proton Therapy, Washington University School of Medicine, believes it is an exciting time in lung cancer.

Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy (SABR), is used to eradicate smaller lung cancers and other cancers as well. Groups have launched trials comparing SABR to illuminated lung resection.

Bradley expects a lot of changes will occur in stage I lung cancer. In systemic therapy the biology of lung cancer is beginning to be characterized which is resulting in multiple personalized therapies for a variety of different subtypes of lung cancer.

These topics, and more, were discussed at the 12th International Lung Cancer Congress and will continue to be discussed into the future.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,